X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (12) 12
pet (9) 9
positron emission tomography (9) 9
positron-emission-tomography (8) 8
[c-11]mdl 100907 (7) 7
5-ht (6) 6
c]mdl 100907 (6) 6
human brain (6) 6
index medicus (6) 6
serotonin (6) 6
[11c]mdl 100907 (5) 5
brain (5) 5
c]cimbi-36 (5) 5
humans (5) 5
pharmacology & pharmacy (5) 5
radiology, nuclear medicine & medical imaging (5) 5
rat-brain (5) 5
serotonin receptors (5) 5
5-ht2a (4) 4
[c-11]cimbi-36 (4) 4
animals (4) 4
chemistry, medicinal (4) 4
f]altanserin (4) 4
in-vivo (4) 4
positron-emission tomography (4) 4
psychiatry (4) 4
receptor, serotonin, 5-ht2a - metabolism (4) 4
[f-18]altanserin (3) 3
agonist (3) 3
antagonist (3) 3
brain - metabolism (3) 3
fluorobenzenes - pharmacokinetics (3) 3
imaging / radiology (3) 3
male (3) 3
medicine & public health (3) 3
neuroimaging (3) 3
pet imaging (3) 3
phenols (3) 3
piperidines - pharmacokinetics (3) 3
radioligand (3) 3
receptor (3) 3
tomography (3) 3
- (2) 2
5-ht 2a receptor (2) 2
5-ht2a receptor (2) 2
5-ht2a receptors (2) 2
5‐ht2a (2) 2
[11c]cimbi-36 (2) 2
[11c]cimbi‐36 (2) 2
[18f]altanserin (2) 2
[c-11]methyl triflate (2) 2
adult (2) 2
antidepressants (2) 2
beta-cit-fe (2) 2
binding (2) 2
biochemical research methods (2) 2
biochemistry & molecular biology (2) 2
brain - diagnostic imaging (2) 2
c-11 mdl-100907 (2) 2
c-11 raclopride binding (2) 2
carbon radioisotopes (2) 2
carbon radioisotopes - pharmacokinetics (2) 2
chemistry, analytical (2) 2
clinical neurology (2) 2
depression (2) 2
ecstasy (2) 2
endogenous dopamine (2) 2
f-18 altanserin (2) 2
f]mh.mz (2) 2
female (2) 2
fenfluramine (2) 2
fluorobenzenes (2) 2
h-3 mdl-100,907 (2) 2
human-brain (2) 2
in-vivo evaluation (2) 2
isotope labeling - methods (2) 2
ligands (2) 2
mdl 100907 (2) 2
mdma (2) 2
measurement (2) 2
monkey (2) 2
neocortex - drug effects (2) 2
nuclear medicine (2) 2
pharmacological characterization (2) 2
piperidines (2) 2
positron-emission tomography - methods (2) 2
potent (2) 2
primate brain (2) 2
quantitative-analysis (2) 2
radiopharmaceuticals (2) 2
radiopharmaceuticals - chemical synthesis (2) 2
receptors (2) 2
sb 242084 (2) 2
schizophrenia (2) 2
serotonin - metabolism (2) 2
serotonin antagonists (2) 2
serotonin antagonists - chemical synthesis (2) 2
test-retest reproducibility (2) 2
tomography, emission-computed (2) 2
tracers (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
NEUROPSYCHOPHARMACOLOGY, ISSN 0893-133X, 05/2012, Volume 37, Issue 6, pp. 1465 - 1473
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 09/2017, Volume 20, Issue 9, pp. 683 - 691
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2006, Volume 149, Issue 7, pp. 861 - 869
Background and purpose: Recent evidence suggests that 5‐HT2C receptor activation may inhibit midbrain 5‐HT neurones by activating neighbouring GABA neurones.... 
dorsal raphe nucleus | [11C]MDL 100907 | 5‐hydroxytryptamine | 5‐HT2C receptor | SB 242084 | WAY 161503 | ANTAGONIST | 5-hydroxytryptamine | AMINOBUTYRIC-ACID NEURONS | 5-HT2C receptor | MICRODIALYSIS | [C-11]MDL 100907 | PHARMACOLOGY & PHARMACY | RAT-BRAIN | FENFLURAMINE | EXPRESSION | SEROTONERGIC NEURONS | PET | AGONIST | Research Papers
Journal Article
Molecular Imaging and Biology, ISSN 1536-1632, 12/2013, Volume 15, Issue 6, pp. 730 - 738
Preclinical positron emission tomography studies are important to follow disease progression and develop new pharmacological agents. We investigated whether... 
5-HT2A receptor | HUMAN BRAIN | Serotonin | Kinetic modeling | REFERENCE TISSUE MODEL | CORTEX | QUANTIFICATION | BEHAVIOR | [C-11]MDL 100907 | Reference tissue | PET | Medicine & Public Health | 5-HT 2A receptor | Imaging / Radiology | [ 11 C]MDL 100907 | receptor | C]MDL 100907 | 5-HT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, ISSN 0362-4803, 06/1998, Volume 41, Issue 6, pp. 545 - 556
The highly reactive labelling agent,[C-11]methyl triflate, was used to synthesise three recently developed PET radioligands. The labelling reactions were... 
CHEMISTRY, ANALYTICAL | CHEMISTRY, MEDICINAL | HUMAN BRAIN | 5-HT1A RECEPTORS | FLB 457 | MDL 100907 | IODIDE | BIOCHEMICAL RESEARCH METHODS | beta-CIT-FE | C-11 METHYL TRIFLATE | DELINEATION | [C-11]methyl triflate | POSITRON EMISSION TOMOGRAPHY | PHARMACOLOGY & PHARMACY
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 3/2011, Volume 38, Issue 3, pp. 576 - 591
Journal Article
SYNAPSE, ISSN 0887-4476, 12/2000, Volume 38, Issue 4, pp. 421 - 431
M100907 (MDL 100907, R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl] -4-piperidinemethanol) is a new selective antagonist of 5-HT2A receptors,... 
whole hemisphere autoradiography | SCHIZOPHRENIC-PATIENTS | POSTMORTEM HUMAN BRAIN | SEROTONIN RECEPTORS | NEUROSCIENCES | PREFRONTAL CORTEX | MESSENGER-RNAS | human brain | [C-11]M100907 | 5-MT2A receptors | POSITRON EMISSION TOMOGRAPHY | [H-3]M100907 | RAT-BRAIN | ANTAGONIST MDL-100,907 | BINDING-SITES | H-3 MDL-100,907
Journal Article